{
  "name": "Synptide Peptide Clinical Trials",
  "version": "1.0",
  "updated": "2026-07-12",
  "source": "ClinicalTrials.gov API v2",
  "sourceLicense": "Public domain (U.S. Government work)",
  "license": "CC BY 4.0 for the Synptide compound tagging; underlying trial records are public domain",
  "citation": "Synptide Peptide Clinical Trials (synptide.com/datasets), sourced from ClinicalTrials.gov",
  "count": 85,
  "trials": [
    {
      "nctId": "NCT06948214",
      "title": "Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency",
      "status": "Recruiting",
      "phase": "PHASE3",
      "sponsor": "Lumos Pharma",
      "conditions": "Growth Hormone Deficiency (GHD)",
      "interventions": "LUM-201; Matched Placebo (Capsules)",
      "enrollment": "150",
      "startDate": "2026-05-20",
      "completionDate": "2027-12",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT06948214"
    },
    {
      "nctId": "NCT07586865",
      "title": "Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction",
      "status": "Not yet recruiting",
      "phase": "PHASE2",
      "sponsor": "Beijing Northland Biotech. Co., Ltd.",
      "conditions": "Acute Myocardial Infarction (AMI); Acute Myocardial Infarction of Anterior Wall; Acute Myocardial Infarction With ST Elevation; Acute Myocardial Infarction of Left Ventricle; Acute Myocardial Infarction With ST Segment Elevation",
      "interventions": "Recombinant Human Thymosin Beta 4 Injection (NL005); Placebo",
      "enrollment": "189",
      "startDate": "2026-05-18",
      "completionDate": "2027-08-17",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT07586865"
    },
    {
      "nctId": "NCT07678073",
      "title": "Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation",
      "status": "Recruiting",
      "phase": "NA",
      "sponsor": "University of Gaziantep",
      "conditions": "Kidney Disease, End-Stage; Kidney Transplant; Kidney; Kidney Disease; Renal Transplant",
      "interventions": "Sevoflurane General Anesthesia; Bupivacaine and Morphine for Combined Spinal-Epidural Anesthesia",
      "enrollment": "68",
      "startDate": "2026-03-01",
      "completionDate": "2026-10-01",
      "hasResults": "no",
      "compounds": "mots-c",
      "url": "https://clinicaltrials.gov/study/NCT07678073"
    },
    {
      "nctId": "NCT07487363",
      "title": "TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD",
      "status": "Recruiting",
      "phase": "PHASE1/PHASE2",
      "sponsor": "Hudson Biotech",
      "conditions": "Atherosclerotic Cardiovascular Diseases; Endothelial Dysfunction",
      "interventions": "TB-500; Placebo",
      "enrollment": "80",
      "startDate": "2026-02-05",
      "completionDate": "2027-02-14",
      "hasResults": "no",
      "compounds": "tb-500; thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT07487363"
    },
    {
      "nctId": "NCT07437547",
      "title": "BPC 157 for Acute Hamstring Muscle Strain Repair",
      "status": "Recruiting",
      "phase": "PHASE2",
      "sponsor": "Hudson Biotech",
      "conditions": "Hamstring Muscle Strain; Skeletal Muscle Injury",
      "interventions": "Pentadecapeptide BPC 157; Placebo",
      "enrollment": "120",
      "startDate": "2026-02-02",
      "completionDate": "2027-02-14",
      "hasResults": "no",
      "compounds": "bpc-157",
      "url": "https://clinicaltrials.gov/study/NCT07437547"
    },
    {
      "nctId": "NCT07481734",
      "title": "Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)",
      "status": "Recruiting",
      "phase": "PHASE2",
      "sponsor": "Hudson Biotech",
      "conditions": "Metabolic Associated Steatotic Liver Disease; Nonalcoholic Steatohepatitis; Hepatic Steatosis",
      "interventions": "Tesamorelin; Placebo; Standardized lifestyle counseling",
      "enrollment": "120",
      "startDate": "2026-02-02",
      "completionDate": "2027-02-14",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT07481734"
    },
    {
      "nctId": "NCT07505745",
      "title": "MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity",
      "status": "Recruiting",
      "phase": "PHASE2",
      "sponsor": "Hudson Biotech",
      "conditions": "Prediabetes; Insulin Resistance; Overweight/Obesity",
      "interventions": "MOTS-c (MDP); Placebo; Route Subcutaneous injection; Regimen",
      "enrollment": "120",
      "startDate": "2026-02-02",
      "completionDate": "2027-02-14",
      "hasResults": "no",
      "compounds": "mots-c",
      "url": "https://clinicaltrials.gov/study/NCT07505745"
    },
    {
      "nctId": "NCT06554717",
      "title": "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV",
      "status": "Recruiting",
      "phase": "PHASE2",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "HIV-1-infection; Frailty; Impaired Physical Function; Abdominal Obesity; Aging",
      "interventions": "Tesamorelin; Placebo; Exercise",
      "enrollment": "100",
      "startDate": "2025-07-10",
      "completionDate": "2028-06-16",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT06554717"
    },
    {
      "nctId": "NCT06219330",
      "title": "Cathelicidin LL-37 Relation to Potentially Malignant Lesions",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Fayoum University",
      "conditions": "Oral Potentially Malignant Lesions",
      "interventions": "",
      "enrollment": "45",
      "startDate": "2023-07-01",
      "completionDate": "2023-10-30",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT06219330"
    },
    {
      "nctId": "NCT05832060",
      "title": "Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia",
      "status": "Unknown",
      "phase": "NA",
      "sponsor": "Bambino Gesù Hospital and Research Institute",
      "conditions": "Developmental Dyslexia",
      "interventions": "Active tDCS; Active tRNS; Sham tRNS or tDCS",
      "enrollment": "24",
      "startDate": "2023-05-01",
      "completionDate": "2025-03-01",
      "hasResults": "no",
      "compounds": "selank",
      "url": "https://clinicaltrials.gov/study/NCT05832060"
    },
    {
      "nctId": "NCT05555589",
      "title": "Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2",
      "status": "Recruiting",
      "phase": "PHASE3",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Neurotrophic Keratopathy",
      "interventions": "RGN-259; Placebo",
      "enrollment": "70",
      "startDate": "2023-04-11",
      "completionDate": "2026-04-30",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT05555589"
    },
    {
      "nctId": "NCT05364684",
      "title": "The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "NAFLD; Nonalcoholic Fatty Liver; NASH - Nonalcoholic Steatohepatitis",
      "interventions": "LUM-201",
      "enrollment": "12",
      "startDate": "2022-08-10",
      "completionDate": "2024-11-22",
      "hasResults": "yes",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT05364684"
    },
    {
      "nctId": "NCT05984134",
      "title": "Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Beijing Northland Biotech. Co., Ltd.",
      "conditions": "Acute Myocardial Infarction",
      "interventions": "NL005 Middle Dose; NL005 High Dose; Placebo",
      "enrollment": "90",
      "startDate": "2022-07-15",
      "completionDate": "2023-05-26",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT05984134"
    },
    {
      "nctId": "NCT06867250",
      "title": "Peri-implant Vitamin D and Cathelicidin (LL-37) Levels",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Altinbas University",
      "conditions": "Peri-Implantitis and Peri-implant Mucositis",
      "interventions": "The patients' periodontal clinical parameters were recorded. PISF samples were collected, and the evaluations of 25(OH)D and LL-37 were conducted using enzyme-linked immunosorbent assay.",
      "enrollment": "33",
      "startDate": "2021-04-01",
      "completionDate": "2021-12-01",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT06867250"
    },
    {
      "nctId": "NCT04861493",
      "title": "Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Cairo University",
      "conditions": "Smoking Reduction",
      "interventions": "",
      "enrollment": "60",
      "startDate": "2021-02-23",
      "completionDate": "2021-02-23",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT04861493"
    },
    {
      "nctId": "NCT05485818",
      "title": "Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Beijing Northland Biotech. Co., Ltd.",
      "conditions": "Acute Myocardial Infarction",
      "interventions": "Low Dose; Middle Dose; High Dose; Placebo",
      "enrollment": "62",
      "startDate": "2020-11-23",
      "completionDate": "2021-09-30",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT05485818"
    },
    {
      "nctId": "NCT01311518",
      "title": "A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction",
      "status": "Withdrawn",
      "phase": "PHASE2",
      "sponsor": "RegeneRx Biopharmaceuticals, Inc.",
      "conditions": "Acute Myocardial Infarction; ST Elevation Myocardial Infarction; STEMI",
      "interventions": "Drug: Placebo; Drug: Injectable Thymosin beta 4",
      "enrollment": "0",
      "startDate": "2019-07",
      "completionDate": "2020-07",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT01311518"
    },
    {
      "nctId": "NCT03937882",
      "title": "Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3",
      "status": "Completed",
      "phase": "PHASE3",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Dry Eye Syndromes; Dry Eye",
      "interventions": "RGN-259; Placebo",
      "enrollment": "700",
      "startDate": "2019-05-24",
      "completionDate": "2020-11-08",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT03937882"
    },
    {
      "nctId": "NCT03826160",
      "title": "Growth Hormone Dynamics and Cardiac Steatosis in HIV",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Human Immunodeficiency Virus; Lipodystrophy; Cardiac Disease",
      "interventions": "",
      "enrollment": "23",
      "startDate": "2019-01-30",
      "completionDate": "2022-04-19",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT03826160"
    },
    {
      "nctId": "NCT03375788",
      "title": "Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Non-Alcoholic Fatty Liver Disease; Obesity; Obesity, Abdominal; Liver Fat; Fatty Liver",
      "interventions": "Tesamorelin; Identical Placebo",
      "enrollment": "51",
      "startDate": "2019-01-17",
      "completionDate": "2024-07-10",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT03375788"
    },
    {
      "nctId": "NCT04555850",
      "title": "A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Beijing Northland Biotech. Co., Ltd.",
      "conditions": "Healthy",
      "interventions": "Recombinant Human Thymosin β4; Placebo",
      "enrollment": "30",
      "startDate": "2018-07-30",
      "completionDate": "2019-02-18",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT04555850"
    },
    {
      "nctId": "NCT03150511",
      "title": "Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury",
      "status": "Recruiting",
      "phase": "PHASE2",
      "sponsor": "Johns Hopkins University",
      "conditions": "Peripheral Nerve Injuries",
      "interventions": "Tesamorelin 2 Milligrams (MG)",
      "enrollment": "36",
      "startDate": "2018-06-01",
      "completionDate": "2027-12",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT03150511"
    },
    {
      "nctId": "NCT03226821",
      "title": "Body Composition and Adipose Tissue in HIV",
      "status": "Terminated",
      "phase": "PHASE4",
      "sponsor": "Columbia University",
      "conditions": "HIV Lipodystrophy Syndrome; Growth Hormone Deficiency; Body Composition",
      "interventions": "Tesamorelin",
      "enrollment": "6",
      "startDate": "2018-02-07",
      "completionDate": "2025-04-30",
      "hasResults": "yes",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT03226821"
    },
    {
      "nctId": "NCT03878706",
      "title": "The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination",
      "status": "Recruiting",
      "phase": "N/A",
      "sponsor": "University of Athens",
      "conditions": "Diabetes Mellitus, Type 2",
      "interventions": "",
      "enrollment": "240",
      "startDate": "2017-11-03",
      "completionDate": "2026-12-31",
      "hasResults": "no",
      "compounds": "liraglutide; mots-c",
      "url": "https://clinicaltrials.gov/study/NCT03878706"
    },
    {
      "nctId": "NCT02553603",
      "title": "The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "The University of Texas Medical Branch, Galveston",
      "conditions": "Mild Cognitive Impairment",
      "interventions": "Growth Hormone Releasing Hormone (GHRH); Placebo Growth Hormone Releasing Hormone",
      "enrollment": "22",
      "startDate": "2017-07-18",
      "completionDate": "2019-01-17",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT02553603"
    },
    {
      "nctId": "NCT04555824",
      "title": "A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Beijing Northland Biotech. Co., Ltd.",
      "conditions": "Healthy",
      "interventions": "Recombinant Human Thymosin β4; Placebo",
      "enrollment": "54",
      "startDate": "2017-07-17",
      "completionDate": "2018-02-20",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT04555824"
    },
    {
      "nctId": "NCT02572323",
      "title": "Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "University of California, San Diego",
      "conditions": "Mild Cognitive Impairment",
      "interventions": "Tesamorelin",
      "enrollment": "73",
      "startDate": "2017-02-15",
      "completionDate": "2023-10-15",
      "hasResults": "yes",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT02572323"
    },
    {
      "nctId": "NCT03031535",
      "title": "Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Dauntless Pharmaceuticals",
      "conditions": "Healthy Volunteer Study",
      "interventions": "Intranasal octreotide acetate; Subcutaneous octreotide acetate; Growth hormone-releasing hormone; Arginine hydrochloride",
      "enrollment": "32",
      "startDate": "2017-01",
      "completionDate": "2017-03",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT03031535"
    },
    {
      "nctId": "NCT02974907",
      "title": "Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2",
      "status": "Completed",
      "phase": "PHASE3",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Dry Eye Syndrome",
      "interventions": "RGN-259; Placebo",
      "enrollment": "601",
      "startDate": "2016-11",
      "completionDate": "2017-09",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT02974907"
    },
    {
      "nctId": "NCT02931474",
      "title": "Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia",
      "status": "Withdrawn",
      "phase": "PHASE2",
      "sponsor": "National Institute of Nursing Research (NINR)",
      "conditions": "Sleep Disorder; Traumatic Brain Injury",
      "interventions": "Tesamorelin; Placebo",
      "enrollment": "0",
      "startDate": "2016-10-06",
      "completionDate": "2017-03-08",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT02931474"
    },
    {
      "nctId": "NCT02806414",
      "title": "Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.",
      "status": "Completed",
      "phase": "PHASE1/PHASE2",
      "sponsor": "University of California, San Diego",
      "conditions": "Rosacea",
      "interventions": "Ivermectin",
      "enrollment": "25",
      "startDate": "2016-07",
      "completionDate": "2019-07",
      "hasResults": "yes",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT02806414"
    },
    {
      "nctId": "NCT02736591",
      "title": "Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response",
      "status": "Unknown",
      "phase": "PHASE3",
      "sponsor": "Cairo University",
      "conditions": "Subfertility",
      "interventions": "DHEA; Growth Hormone-Releasing Hormone; Placebo 1; Placebo 2",
      "enrollment": "210",
      "startDate": "2016-06",
      "completionDate": "2017-04",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT02736591"
    },
    {
      "nctId": "NCT02138591",
      "title": "Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.",
      "status": "Withdrawn",
      "phase": "PHASE3",
      "sponsor": "University of Missouri, Kansas City",
      "conditions": "Vitamin d Deficiency",
      "interventions": "Blood draw pre-operatively; Blood draw post-operative Day 1; Blood draw post-operative Day 2",
      "enrollment": "0",
      "startDate": "2016-02",
      "completionDate": "2016-05",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT02138591"
    },
    {
      "nctId": "NCT06133946",
      "title": "Cohort Of DEafness-gene Screening",
      "status": "Active not recruiting",
      "phase": "N/A",
      "sponsor": "Affiliated Hospital of Nantong University",
      "conditions": "Hearing Loss",
      "interventions": "Genetic screening test (Deafness gene variant detection array kit)",
      "enrollment": "35920",
      "startDate": "2016-01-01",
      "completionDate": "2021-03-31",
      "hasResults": "no",
      "compounds": "mots-c",
      "url": "https://clinicaltrials.gov/study/NCT06133946"
    },
    {
      "nctId": "NCT02637284",
      "title": "PCO-02 - Safety and Pharmacokinetics Trial",
      "status": "Unknown",
      "phase": "PHASE1",
      "sponsor": "PharmaCotherapia d.o.o.",
      "conditions": "Healthy Volunteers",
      "interventions": "Bepecin; Placebo",
      "enrollment": "42",
      "startDate": "2015-10",
      "completionDate": "2016-02",
      "hasResults": "no",
      "compounds": "bpc-157",
      "url": "https://clinicaltrials.gov/study/NCT02637284"
    },
    {
      "nctId": "NCT02597803",
      "title": "Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1",
      "status": "Completed",
      "phase": "PHASE2/PHASE3",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Dry Eye Syndrome",
      "interventions": "RGN-259; Placebo",
      "enrollment": "317",
      "startDate": "2015-09",
      "completionDate": "2016-06",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT02597803"
    },
    {
      "nctId": "NCT02196831",
      "title": "Tesamorelin Effects on Liver Fat and Histology in HIV",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Human Immunodeficiency Virus (HIV); Nonalcoholic Fatty Liver Disease (NAFLD); Nonalcoholic Steatohepatitis (NASH)",
      "interventions": "tesamorelin; Placebo",
      "enrollment": "61",
      "startDate": "2015-07-01",
      "completionDate": "2019-01-16",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT02196831"
    },
    {
      "nctId": "NCT02271282",
      "title": "Estradiol-Receptor Blockade in Older Men and Women",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Mayo Clinic",
      "conditions": "Normal Healthy Volunteers",
      "interventions": "Toremifene; Placebo; GHRH/Ghrelin combined Injection",
      "enrollment": "40",
      "startDate": "2014-12",
      "completionDate": "2016-05",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT02271282"
    },
    {
      "nctId": "NCT04027712",
      "title": "Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD",
      "status": "Unknown",
      "phase": "N/A",
      "sponsor": "University of Athens",
      "conditions": "Diabetes; Clopidogrel Resistance; Amyloid; Insulin Resistance",
      "interventions": "",
      "enrollment": "120",
      "startDate": "2014-01-01",
      "completionDate": "2019-12-31",
      "hasResults": "no",
      "compounds": "mots-c",
      "url": "https://clinicaltrials.gov/study/NCT04027712"
    },
    {
      "nctId": "NCT02507245",
      "title": "Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Stefania La Grutta, MD",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "Growth Hormone-Releasing Hormone",
      "enrollment": "48",
      "startDate": "2014-01",
      "completionDate": "2015-04",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT02507245"
    },
    {
      "nctId": "NCT01632592",
      "title": "Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue",
      "status": "Withdrawn",
      "phase": "NA",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Abdominal Obesity",
      "interventions": "Tesamorelin; Placebo",
      "enrollment": "0",
      "startDate": "2014-01",
      "completionDate": "2014-01",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01632592"
    },
    {
      "nctId": "NCT01579695",
      "title": "Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®",
      "status": "Terminated",
      "phase": "N/A",
      "sponsor": "Theratechnologies",
      "conditions": "HIV",
      "interventions": "Tesamorelin for injection",
      "enrollment": "391",
      "startDate": "2013-02",
      "completionDate": "2018-05",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01579695"
    },
    {
      "nctId": "NCT01747200",
      "title": "Effects of Transcranial Magnetic Stimulation on Object Recognition",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)",
      "conditions": "Repetitive TMS (rTMS); Sham rTMS; Bilateral rTMS; Unilateral rTMS",
      "interventions": "Sham rTMS; Bilateral rTMS at same frequency and in phase; Bilateral rTMS at different frequencies; Bilateral rTMSat same frequency and out of phase; rTMS over TP8; rTMS over TP7",
      "enrollment": "13",
      "startDate": "2012-11-16",
      "completionDate": "2017-01-26",
      "hasResults": "no",
      "compounds": "selank",
      "url": "https://clinicaltrials.gov/study/NCT01747200"
    },
    {
      "nctId": "NCT01591902",
      "title": "Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®",
      "status": "Terminated",
      "phase": "PHASE4",
      "sponsor": "Theratechnologies",
      "conditions": "Diabetic Retinopathy; HIV",
      "interventions": "Tesamorelin; Placebo-Control",
      "enrollment": "129",
      "startDate": "2012-06",
      "completionDate": "2018-05",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01591902"
    },
    {
      "nctId": "NCT01788462",
      "title": "Egrifta Replacement and Sleep Disordered Breathing",
      "status": "Withdrawn",
      "phase": "N/A",
      "sponsor": "Johns Hopkins University",
      "conditions": "Lipodystrophy",
      "interventions": "Tesamorelin (Egrifta)",
      "enrollment": "0",
      "startDate": "2012-05",
      "completionDate": "2020-01",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01788462"
    },
    {
      "nctId": "NCT03923218",
      "title": "Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "Gazi University",
      "conditions": "Periodontitis",
      "interventions": "LL-37 levels in Gingival crevicular fluid; Serum Vitamin D3 levels; Clinical parameters",
      "enrollment": "60",
      "startDate": "2011-12",
      "completionDate": "2012-07",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT03923218"
    },
    {
      "nctId": "NCT01388920",
      "title": "Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "Theratechnologies",
      "conditions": "Chronic Obstructive Pulmonary Disease (COPD)",
      "interventions": "Tesamorelin; Placebo",
      "enrollment": "3",
      "startDate": "2011-09",
      "completionDate": "2011-12",
      "hasResults": "yes",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01388920"
    },
    {
      "nctId": "NCT01387347",
      "title": "Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Dry Eye Syndrome; Dry Eye",
      "interventions": "Thymosin beta 4; Placebo",
      "enrollment": "72",
      "startDate": "2011-08",
      "completionDate": "2011-10",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT01387347"
    },
    {
      "nctId": "NCT01398280",
      "title": "Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation",
      "status": "Completed",
      "phase": "EARLY_PHASE1",
      "sponsor": "University of California, San Diego",
      "conditions": "Rosacea",
      "interventions": "Topical aminocaproic acid (ACA) mixed with Vanicream; Vehicle cream",
      "enrollment": "15",
      "startDate": "2011-07",
      "completionDate": "2012-12",
      "hasResults": "yes",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT01398280"
    },
    {
      "nctId": "NCT01372995",
      "title": "Vitamin D in Ventilated ICU Patients",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Emory University",
      "conditions": "Respiratory Failure",
      "interventions": "Enteral Vitamin D3 50,000 IU; Enteral Vitamin D3 100,000IU; Inactive substance",
      "enrollment": "31",
      "startDate": "2011-07",
      "completionDate": "2014-04",
      "hasResults": "yes",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT01372995"
    },
    {
      "nctId": "NCT01410799",
      "title": "Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "University of Pennsylvania",
      "conditions": "Hormone Deficiency; Aging",
      "interventions": "Growth Hormone Releasing Hormone (GHRH )",
      "enrollment": "13",
      "startDate": "2011-05",
      "completionDate": "2011-06",
      "hasResults": "yes",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT01410799"
    },
    {
      "nctId": "NCT01280344",
      "title": "Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Helsinn Therapeutics (U.S.), Inc",
      "conditions": "Gastrointestinal Dysmotility",
      "interventions": "Saline Solution for Injection; Ipamorelin",
      "enrollment": "320",
      "startDate": "2011-04",
      "completionDate": "2013-06",
      "hasResults": "no",
      "compounds": "ipamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01280344"
    },
    {
      "nctId": "NCT01393132",
      "title": "Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Michigan Cornea Consultants, PC",
      "conditions": "Dry Eye; Sjogren's Syndrome; Graft vs. Host Disease",
      "interventions": "Thymosin Beta 4 eye drops; Vehicle Control",
      "enrollment": "9",
      "startDate": "2011-03",
      "completionDate": "2012-12",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT01393132"
    },
    {
      "nctId": "NCT01359488",
      "title": "VRS-317 in Adult Subjects With Growth Hormone Deficiency",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Versartis Inc.",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "VRS-317; VRS-317; VRS-317; VRS-317; VRS-317",
      "enrollment": "50",
      "startDate": "2011-03",
      "completionDate": "2012-06",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT01359488"
    },
    {
      "nctId": "NCT01263717",
      "title": "Effects of Growth Hormone Releasing Hormone in HIV",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "HIV; HIV Lipodystrophy",
      "interventions": "tesamorelin; placebo",
      "enrollment": "54",
      "startDate": "2010-12",
      "completionDate": "2014-02",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01263717"
    },
    {
      "nctId": "NCT01343641",
      "title": "Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects",
      "status": "Withdrawn",
      "phase": "PHASE2",
      "sponsor": "University of Virginia",
      "conditions": "Chronic Kidney Disease; Kidney Disease",
      "interventions": "MK-0677; Placebo",
      "enrollment": "0",
      "startDate": "2009-03",
      "completionDate": "2010-04",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT01343641"
    },
    {
      "nctId": "NCT00795210",
      "title": "Effects of Short-term Growth Hormone in HIV-infected Patients",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "HIV Lipodystrophy",
      "interventions": "Growth hormone; Growth Hormone Releasing Hormone",
      "enrollment": "25",
      "startDate": "2009-02",
      "completionDate": "2012-11",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00795210"
    },
    {
      "nctId": "NCT00850564",
      "title": "Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Healthy Volunteers",
      "interventions": "Growth Hormone Releasing Hormone (Tesamorelin)",
      "enrollment": "15",
      "startDate": "2009-02",
      "completionDate": "2010-04",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00850564"
    },
    {
      "nctId": "NCT00788320",
      "title": "Vitamin D in Active Tuberculosis (TB) Study",
      "status": "Withdrawn",
      "phase": "NA",
      "sponsor": "Atlanta VA Medical Center",
      "conditions": "Tuberculosis",
      "interventions": "Vitamin D3; Placebo",
      "enrollment": "0",
      "startDate": "2008-10",
      "completionDate": "2010-02",
      "hasResults": "no",
      "compounds": "ll-37",
      "url": "https://clinicaltrials.gov/study/NCT00788320"
    },
    {
      "nctId": "NCT00675506",
      "title": "Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Massachusetts General Hospital",
      "conditions": "Abdominal Obesity; Growth Hormone Deficiency",
      "interventions": "Growth hormone releasing hormone (GHRH) 1-44; Placebo",
      "enrollment": "60",
      "startDate": "2008-07",
      "completionDate": "2012-01",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00675506"
    },
    {
      "nctId": "NCT02012556",
      "title": "Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients",
      "status": "Completed",
      "phase": "PHASE1",
      "sponsor": "Theratechnologies",
      "conditions": "HIV",
      "interventions": "Tesamorelin",
      "enrollment": "18",
      "startDate": "2008-05",
      "completionDate": "2008-07",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT02012556"
    },
    {
      "nctId": "NCT00743769",
      "title": "A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers",
      "status": "Withdrawn",
      "phase": "PHASE1",
      "sponsor": "RegeneRx Biopharmaceuticals, Inc.",
      "conditions": "Myocardial Infarction; Myocardial Ischemia",
      "interventions": "thymosin beta 4; Placebo",
      "enrollment": "0",
      "startDate": "2008-04",
      "completionDate": "2017-01-01",
      "hasResults": "no",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT00743769"
    },
    {
      "nctId": "NCT00672074",
      "title": "Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Helsinn Therapeutics (U.S.), Inc",
      "conditions": "Ileus",
      "interventions": "Ipamorelin; placebo",
      "enrollment": "117",
      "startDate": "2008-04",
      "completionDate": "2009-12",
      "hasResults": "no",
      "compounds": "ipamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00672074"
    },
    {
      "nctId": "NCT00807365",
      "title": "Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "Johns Hopkins University",
      "conditions": "Elderly",
      "interventions": "GHRH",
      "enrollment": "5",
      "startDate": "2007-12-17",
      "completionDate": "2010-04-29",
      "hasResults": "yes",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00807365"
    },
    {
      "nctId": "NCT00598871",
      "title": "A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "ReGenTree, LLC",
      "conditions": "Diabetes",
      "interventions": "Thymosin Beta 4 (Tβ4); Placebo",
      "enrollment": "12",
      "startDate": "2007-12",
      "completionDate": "2009-02",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT00598871"
    },
    {
      "nctId": "NCT00608023",
      "title": "TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy",
      "status": "Completed",
      "phase": "PHASE3",
      "sponsor": "Theratechnologies",
      "conditions": "Lipodystrophy; HIV Infections",
      "interventions": "Tesamorelin; Placebo for Tesamorelin",
      "enrollment": "263",
      "startDate": "2007-08",
      "completionDate": "2008-10",
      "hasResults": "yes",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00608023"
    },
    {
      "nctId": "NCT00324064",
      "title": "Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Children's Mercy Hospital Kansas City",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "GHRH/arginine stimulation testing",
      "enrollment": "90",
      "startDate": "2007-07",
      "completionDate": "2009-07",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00324064"
    },
    {
      "nctId": "NCT00720902",
      "title": "Adult Growth Hormone Deficiency and Cardiovascular Risk",
      "status": "Terminated",
      "phase": "PHASE4",
      "sponsor": "Columbia University",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "Blood draws; growth hormone releasing hormone (GHRH) & arginine; Carotid ultrasound; MRI; Endothelial cell biopsy",
      "enrollment": "7",
      "startDate": "2007-02",
      "completionDate": "2010-03",
      "hasResults": "yes",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00720902"
    },
    {
      "nctId": "NCT00395291",
      "title": "Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "University of Virginia",
      "conditions": "Chronic Kidney Disease; End Stage Renal Disease",
      "interventions": "MK-0677; Placebo",
      "enrollment": "49",
      "startDate": "2006-08",
      "completionDate": "2009-01",
      "hasResults": "yes",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT00395291"
    },
    {
      "nctId": "NCT00832091",
      "title": "Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "RegeneRx Biopharmaceuticals, Inc.",
      "conditions": "Venous Stasis Ulcers",
      "interventions": "Thymosin Beta 4; Placebo",
      "enrollment": "72",
      "startDate": "2006-07",
      "completionDate": "2009-01",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT00832091"
    },
    {
      "nctId": "NCT00382174",
      "title": "Study of Thymosin Beta 4 in Patients With Pressure Ulcers",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "RegeneRx Biopharmaceuticals, Inc.",
      "conditions": "Pressure Ulcers",
      "interventions": "Placebo; Thymosin Beta 4",
      "enrollment": "72",
      "startDate": "2006-05",
      "completionDate": "2008-12",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT00382174"
    },
    {
      "nctId": "NCT00311766",
      "title": "A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "RegeneRx Biopharmaceuticals, Inc.",
      "conditions": "Epidermolysis Bullosa",
      "interventions": "Thymosin Beta 4; Placebo",
      "enrollment": "30",
      "startDate": "2006-02",
      "completionDate": "2010-07",
      "hasResults": "yes",
      "compounds": "thymosin-beta-4",
      "url": "https://clinicaltrials.gov/study/NCT00311766"
    },
    {
      "nctId": "NCT00257712",
      "title": "SMART: Somatotrophics, Memory, and Aging Research Trial",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "University of Washington",
      "conditions": "Aging; Mild Cognitive Impairment",
      "interventions": "TH9507 human growth hormone releasing hormone (GHRH)",
      "enrollment": "151",
      "startDate": "2006-02",
      "completionDate": "2011-12",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00257712"
    },
    {
      "nctId": "NCT00267527",
      "title": "A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "ConjuChem",
      "conditions": "Obesity; HIV Infections",
      "interventions": "CJC 1295",
      "enrollment": "120",
      "startDate": "2005-12",
      "completionDate": "",
      "hasResults": "no",
      "compounds": "cjc-1295",
      "url": "https://clinicaltrials.gov/study/NCT00267527"
    },
    {
      "nctId": "NCT00128115",
      "title": "Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)",
      "status": "Terminated",
      "phase": "PHASE2",
      "sponsor": "Merck Sharp & Dohme LLC",
      "conditions": "Hip Fracture",
      "interventions": "MK0677",
      "enrollment": "83",
      "startDate": "2005-09",
      "completionDate": "2007-08",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT00128115"
    },
    {
      "nctId": "NCT00116129",
      "title": "Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Bennett, Robert, M.D.",
      "conditions": "Fibromyalgia",
      "interventions": "Ibutamoren Mesylate (MK-0677)",
      "enrollment": "64",
      "startDate": "2005-07",
      "completionDate": "2008-01",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT00116129"
    },
    {
      "nctId": "NCT00123253",
      "title": "TH9507 in Patients With HIV-Associated Lipodystrophy",
      "status": "Completed",
      "phase": "PHASE3",
      "sponsor": "Theratechnologies",
      "conditions": "HIV Infections; Lipodystrophy",
      "interventions": "TH9507",
      "enrollment": "412",
      "startDate": "2005-06",
      "completionDate": "2006-11",
      "hasResults": "no",
      "compounds": "sermorelin; tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT00123253"
    },
    {
      "nctId": "NCT00791843",
      "title": "The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "University of Pennsylvania",
      "conditions": "Congestive Heart Failure",
      "interventions": "Growth hormone releasing hormone/ placebo",
      "enrollment": "3",
      "startDate": "2004-03",
      "completionDate": "2011-08",
      "hasResults": "yes",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00791843"
    },
    {
      "nctId": "NCT01060488",
      "title": "Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency",
      "status": "Completed",
      "phase": "PHASE3",
      "sponsor": "Merck KGaA, Darmstadt, Germany",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "GHRH+Arg, GHRH+Arg, ITT; ITT, ITT, GHRH+Arg.",
      "enrollment": "69",
      "startDate": "2004-01",
      "completionDate": "2005-11",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT01060488"
    },
    {
      "nctId": "NCT00074529",
      "title": "Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Merck Sharp & Dohme LLC",
      "conditions": "Alzheimer's Disease",
      "interventions": "MK0677",
      "enrollment": "512",
      "startDate": "2003-10",
      "completionDate": "2006-01",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT00074529"
    },
    {
      "nctId": "NCT01264497",
      "title": "Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes",
      "status": "Completed",
      "phase": "PHASE2",
      "sponsor": "Theratechnologies",
      "conditions": "Type 2 Diabetes",
      "interventions": "TH9507",
      "enrollment": "55",
      "startDate": "2002-02",
      "completionDate": "2002-11",
      "hasResults": "no",
      "compounds": "tesamorelin",
      "url": "https://clinicaltrials.gov/study/NCT01264497"
    },
    {
      "nctId": "NCT03018886",
      "title": "Diagnosing Adult Growth Hormone Deficiency",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "Helsinki University Central Hospital",
      "conditions": "Growth Hormone Deficiency",
      "interventions": "GHRH plus arginine test",
      "enrollment": "160",
      "startDate": "2001-05",
      "completionDate": "2008-12",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT03018886"
    },
    {
      "nctId": "NCT00474279",
      "title": "Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults",
      "status": "Completed",
      "phase": "PHASE1/PHASE2",
      "sponsor": "University of Virginia",
      "conditions": "Aging",
      "interventions": "Orally active growth hormone secretagogue (MK-677)",
      "enrollment": "72",
      "startDate": "1998-07",
      "completionDate": "",
      "hasResults": "no",
      "compounds": "mk-677",
      "url": "https://clinicaltrials.gov/study/NCT00474279"
    },
    {
      "nctId": "NCT00000380",
      "title": "Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances",
      "status": "Completed",
      "phase": "NA",
      "sponsor": "University of Washington",
      "conditions": "Sleep Disorders",
      "interventions": "GHRH",
      "enrollment": "",
      "startDate": "1996-06",
      "completionDate": "2007-07",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00000380"
    },
    {
      "nctId": "NCT00004332",
      "title": "Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly",
      "status": "Completed",
      "phase": "N/A",
      "sponsor": "National Center for Research Resources (NCRR)",
      "conditions": "Acromegaly",
      "interventions": "",
      "enrollment": "148",
      "startDate": "1993-05",
      "completionDate": "",
      "hasResults": "no",
      "compounds": "sermorelin",
      "url": "https://clinicaltrials.gov/study/NCT00004332"
    }
  ]
}